NenoVision, Czech Republic, a leading innovator in advanced microscopy solutions, has been honored with the esteemed R&D 100 Award in the Analytical\/Test category. This recognition underscores NenoVision’s commitment to pushing the boundaries of scientific innovation and excellence in the field of in-situ correlative microscopy.<\/p>\n
For over 60 years, the R&D 100 Awards have celebrated groundbreaking technologies and innovations across various industries. Winning in the Analytical\/Test category highlights the significant impact of NenoVision’s AFM-in-SEM LiteScope technology, which has revolutionized how researchers and industry professionals analyze and understand complex materials at nanoscale.<\/p>\n
NenoVision’s AFM-in-SEM LiteScope is a unique tool for multimodal in-situ correlative sample analysis, offering a combination of Atomic Force Microscopy (AFM) integrated within a Scanning Electron Microscope (SEM). This innovative approach allows for simultaneous observation and measurement, facilitating a deeper understanding of material behaviors and characteristics that were previously challenging to achieve.<\/p>\n
Umberto Celano, Nanoelectronics Metrology & Failure Analysis Lab group leader and associate professor at Arizona State University, remarked on the LiteScope’s capabilities: \u201cThe LiteScope 2.5 by NenoVision represents a groundbreaking technology that deserves recognition by the R&D 100 Awards. Its advanced capabilities and seamless integration have significantly enhanced our research capabilities, setting a new standard for future innovations in the field of nanoelectronics.\u201d<\/p>\n
\u201cWe are thrilled to receive this prestigious recognition,\u201d said Jan Neuman, CEO of NenoVision. \u201cThe R&D 100 Award is a testament to our team’s dedication and hard work. This award motivates us to continue innovating and delivering cutting-edge solutions that drive scientific discovery and industrial progress.\u201d<\/p>\n
NenoVision looks forward to continuing its mission of enabling scientific breakthroughs and supporting the global research community with its state-of-the-art technologies.<\/p>\n
<\/p>\n
<\/p>\n
For more information:<\/p>\n
NenoVision<\/p>\n